6-K ·Filed Aug 4, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Filing ingested — full details in report page.
Latest settled — T+20d
INCR ▲ +14.43% at T+20d
NEUTRAL call +14.43% · α vs SPY +15.67% · entry $4.82 → $5.51
Latest observation: T+57 -9.43% FF3 residual α
T+1d
-1.14%
call -1.14% · α -0.94%
$4.76
settled 3mo ago
T+5d
-0.31%
call -0.31% · α -0.21%
$4.80
settled 3mo ago
T+20d
+14.43%
call +14.43% · α +15.67%
$5.51
settled 8w ago
T+60d
Pending
in 10h
Price Chart
Loading chart...
Executive Summary
No summary provided
Financial Impact
Not specified
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-035938 |
| Document: 0001493152-26-035938-index-headers.html | 0001493152-26-035938 |
| Document: 0001493152-26-035938-index.html | 0001493152-26-035938 |
| Document: 0001493152-26-035938.txt | 0001493152-26-035938 |
5 reports for INCR
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 24, 2026 9w ago | 6-K | $5.48 $5.39 | ▼ −1.64% | ▼ −2.96% | $4.47 (−18.43%) |
Aug 4, 2026 12w ago | 6-K | $4.82 $5.51 | ▲ +14.43% | ▲ +15.67% | $4.47 (−7.17%) |
Jun 15, 2026 19w ago | 6-K | $0.9550 $0.9545 | ▼ −0.05% | ▼ −0.05% | $4.47 (+368.06%) |
Apr 30, 2026 25w ago | Press Release | $0.8880 $1.07 | ▲ +20.50% | ▲ +15.21% | $4.47 (+403.38%) |
Apr 30, 2026 25w ago | 20-F | $0.8880 $1.07 | ▼ −20.50% | ▼ −15.23% | $4.47 (−403.38%) |
Showing 5 of 5
US Market Status
Market Closed — Opens Thu (11h 54m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers